mesenchymal stem cells

Electrically conductive hydrogels may hold the power to advance the use of stem cells for neural engineering. 

Humans have more in common with cows than mice when it boils down to bone marrow stem cells.

Researchers unravel the mystery of epithelial to mesenchymal transition in acute lymphoblastic leukemia with co-culture techniques, CRISPR-screening, and RNA sequencing.

Using a 3D culture system that imitates fatty tissue, researchers developed a simpler process to study mesenchymal stem cell aging and tissue regeneration.

How stem cells in human teeth respond to different environmental conditions offers clues for regenerative medicine.

As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.

Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.

The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.

Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 

Adding or removing water changes how stem cells differentiate.

The technique, demonstrated in mice using engineered mesenchymal stem cells, has potential for both diagnosis and treatment.

These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.

See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.

Paolo Bianco crusaded against cell therapy fraud and hype.

Researchers show organoids grown from human stem cells can excrete urine when implanted in rats and pigs.

A decade of research on intercellular mitochondrial transfer has answered some long-standing questions and raised new ones.

A screen of 9,000 small molecules identifies a treatment that improves the targeting of mesenchymal stem cells to sites of damaged tissue.